Physiotherapy
Volume 95, Issue 3 , Pages 157-163 , September 2009

Physiotherapy and Guillain–Barré syndrome: results of a national survey

  • Ian Davidson

      Affiliations

    • School of Nursing, Midwifery and Social Work, University of Manchester, Manchester M13 9PL, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 0161 306 7637.
    • ,
  • Charlotte Wilson

      Affiliations

    • School of Nursing, Midwifery and Social Work, University of Manchester, Manchester M13 9PL, UK
    • ,
  • Timothy Walton

      Affiliations

    • Central Manchester Foundation Trust at Trafford General Hospital, Intermediate Neuro Rehabilitation Unit, Urmston, Manchester M41 5SL, UK
    • ,
  • Shirley Brissenden

      Affiliations

    • Central Manchester Foundation Trust at Trafford General Hospital, Intermediate Neuro Rehabilitation Unit, Urmston, Manchester M41 5SL, UK

References 

  1. Rees J, Thompson R, Hughes R. Epidemiological study of Guillain–Barré syndrome in south east England. J Neurol Neurosurg Psychiatr. 1998;64:74–77
  2. Chio A, Cocito D, Leone M, Giordana M, Mora G, Mutani R. Guillain–Barre syndrome: a prospective, population-based incidence and outcome survey. Neurology. 2003;60:1146–1150
  3. Govoni V, Granieri E. Epidemiology of Guillain–Barré syndrome. Curr Opin Neurol. 2001;14:605–613
  4. Ravasio M, Pasquinelle B, Curro Dossi B, Neri W, Guidi C, Gessaroli M, et al. A prospective study on the incidence and prognosis of Guillain–Barré syndrome in Emilia-Romagna Region, Italy (1992–1993). Neurology. 1997;48:214–221
  5. Van Koningsveld R, Van Doorn P, Schmitz P, Ang C, van der Meché F. Mild form of Guillain–Barré syndrome in an epidemiologic survey in the Netherland. Neurology. 2000;54:620
  6. Meythaler J. Rehabilitation of Guillain–Barre syndrome. Arch Phys Med Rehabil. 1997;78:872–879
  7. Meythaler JM, DeVivo MJ, Braswell WC. Rehabilitation outcomes of patients who have developed Guillain–Barre syndrome. Am J Phys Med Rehabil. 1997;76:411–419
  8. Jiang G, Cheng Q, Link H, de Pedro-Cuesta J. Epidemiological features of Guillain–Barre syndrome in Sweden, 1978–93. J Neurol Neurosurg Psychiatr. 1997;62:447–453
  9. Hughes RA, Cornblath DR. Guillain–Barre syndrome. Lancet. 2005;366:1653–1666
  10. Bernsen R, de Jager A, Schmitz P, van der Meché F. Residual physical outcome and daily living 3 to 6 years after Guillain–Barre syndrome. Neurology. 1999;53:409–410
  11. Fletcher D, Lawn N, Wolter T, Wijdicks E. Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation. Neurology. 2000;54:2311–2315
  12. Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, et al. Physical training and fatigue, fitness, and quality of life in Guillain–Barre syndrome and CIDP. Neurology. 2004;63:2393–2395
  13. Carroll A, McDonnell G, Barnes M. A review of the management of Guillain–Barre syndrome in a regional neurological rehabilitation unit. Int J Rehabil Res. 2003;26:297–302
  14. Lennon S, Koblar R, Hughes J, Goeller J, Riser A. Reasons for persistent disability on Guillain–Barre syndrome. Clin Rehabil. 1993;7:1–8
  15. Walton T, Vincent M, Richards J, Davidson I. Usefulness of digital gait analysis for assessing patients with Guillain–Barré syndrome. Int J Ther Rehabil. 2005;12:388–393
  16. Tuckey J, Greenwood R. Rehabilitation after severe Guillain–Barre syndrome: the use of partial body weight support. Physiother Res Int. 2004;9:96–103
  17. Pitetti K, Barrett P, Dilawer Abbas B. Endurance exercise training in Guillain–Barré syndrome. Arch Phys Med Rehabil. 1993;74:761–765
  18. Karni Y, Archdeacon L, Mills K, Wiles C. Clinical assessment and physiotherapy in Guillain–Barre syndrome. Physiotherapy. 1984;70:288–292
  19. Karavatas SG. The role of neurodevelopmental sequencing in the physical therapy management of a geriatric patient with Guillain–Barre syndrome. Top Geriatr Rehabil. 2005;21:133–135
  20. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  21. Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36). I Conceptual framework and item selection. Med Care. 1992;30:473–483
  22. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–1123
  23. Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology. 1999;53:1648–1654
  24. Hughes J, Newsom-Davis J, Perkin G, Pierce J. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 1978;2:750–753
  25. Hughes R, Swan A, Raphael J, Annane D, Van Koningsveld R, van Doorn PA. Immunotherapy for Guillain–Barré syndrome: a systematic review. Brain Adv Access. 2007;1–13
  26. Plasma Exchange/Sandoglobulin Guillain–Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barré syndrome. Lancet. 1997;349:225–230
  27. van der Meché F, Schmitz P. A randomised trial comparing intravenous immune globulin and plasma exchange in Guillain–Barré syndrome. Dutch Guillain–Barré Study Group. N Engl J Med. 1992;326:1123–1129
  28. de Jager AE, Minderhoud JM. Residual signs in severe Guillain–Barre syndrome: analysis of 57 patients. J Neurol Sci. 1991;104:151–156
  29. Garssen MP, Blok JH, van Doorn PA, Visser GH. Conduction velocity distribution in neurologically well-recovered but fatigued Guillain–Barre syndrome patients. Muscle Nerve. 2006;33:177–182
  30. Bernsen RA, de Jager AE, Schmitz PI, van der Meche FG. Long-term impact on work and private life after Guillain–Barre syndrome. J Neurol Sci. 2002;213–217

PII: S0031-9406(09)00032-7

doi: 10.1016/j.physio.2009.04.001

Physiotherapy
Volume 95, Issue 3 , Pages 157-163 , September 2009

Article Tools

* Image Usage & Resolution